Devices

In this Exclusive Interview, Kevin Sayer  talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the Dexcom G6 CGM System and how the future of CGM will affect the way not only type 1, but also type 2 and prediabetes are treated.

In this Exclusive Interview transcript, Kevin Sayer  talks with Diabetes in Control Publisher Steve Freed  about the Dexcom G6 CGM System and the future of CGMs changing diabetes management for type 1, type 2, and even prediabetes. Click here to view the video interview. Steve Freed: This is Steve Freed …

By Sheri R. Colberg, PhD, FACSM
What do you do when someone asks you to participate in a physical activity on the spur of the moment, but you just took some insulin? You may be stuck trying to compensate for this activity entirely with food, but you may have some newer options that come from technology. For starters, if you wear a pump you can choose to lower your basal insulin delivery, and you can use its insulin-on-board calculator to see how much insulin you need to offset with either insulin reductions or food intake. However, just using your blood glucose meter can help you stay on top of your glucose levels, so check often during the activity.

Increased heart rate changes are one initial sign for hypoglycemia episode.

Recently a pump user reported a sudden increase in her glucose levels lasting a couple of days. Her blood sugars were elevated to 275-320mg/dL, with no ketones present.  Changing her infusion sets did not help. Nor did rotating to a new injection site or even using a fresh vial of insulin. After reviewing her insulin pump we noticed a symbol on her “home screen” saying that a special feature was running.

In this Exclusive Interview, Tim Dunn talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the work of Abbott on CGM use and how the FreeStyle Libre system is helping a variety of patients with diabetes.

New technologies have the potential to revolutionize diabetes care. But what are the advantages and disadvantages of insulin pumps, vs. daily injections? How widely will they be adopted, by patients with type 2 diabetes as well as type 1? What factors will make a difference for adoption – convenience, accuracy, costs? In November, we asked you to help us examine the future of insulin delivery and find the answers to these questions. Now we’re sharing all the results with you, so that you can see for yourself how your fellow members of the diabetes community plan on using CGMs, now and in the future.

In this week's Homerun Slides, understanding the sensor procedure for the Eversense CGM.

In this week's Homerun Slides, explaining how the Eversense CGM System works.

In this week's Homerun Slides, we begin a review of the new Eversense CGM system.